Jefferies Assigns 65–75% Probability of Best-in-Class Efficacy for Definium Therapeutics, Inc.’s (DFTX) DT120 in Phase III
Yahoo Finance·2026-02-19 02:32
Definium Therapeutics, Inc. (NASDAQ:DFTX) is among the 7 Most Promising Psychedelic Stocks According to Hedge Funds. Jefferies Assigns 65–75% Probability of Best-in-Class Efficacy for Definium Therapeutics, Inc.'s (DFTX) DT120 in Phase III The third stock on our list of most promising stocks is Definium Therapeutics, Inc. (NASDAQ:DFTX). TheFly reported on January 30 that Jefferies initiated coverage of DFTX with a Buy rating and a $30 price target. The firm highlighted that a single dose of DT120, which ...